Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
10.68
-0.78 (-6.81%)
At close: Jun 27, 2025, 4:00 PM
10.68
0.00 (0.00%)
After-hours: Jun 27, 2025, 4:34 PM EDT
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $277.19 million as of June 27, 2025. Its market cap has decreased by -49.32% in one year.
Market Cap
277.19M
Enterprise Value
110.82M
1-Year Change
-49.32%
Ranking
Category
Stock Price
$10.68
Market Cap Chart
Since June 22, 2016, Cartesian Therapeutics's market cap has increased from $236.80M to $277.19M, an increase of 17.06%. That is a compound annual growth rate of 1.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 277.20M | -39.10% |
| Dec 31, 2024 | 455.20M | 325.42% |
| Dec 29, 2023 | 107.00M | -38.11% |
| Dec 30, 2022 | 172.90M | -54.54% |
| Dec 31, 2021 | 380.30M | 16.19% |
| Dec 31, 2020 | 327.30M | 185.35% |
| Dec 31, 2019 | 114.70M | 92.13% |
| Dec 31, 2018 | 59.70M | -72.75% |
| Dec 29, 2017 | 219.10M | -29.78% |
| Dec 30, 2016 | 312.00M | 31.76% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |